- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00406263
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls
July 25, 2016 updated by: Rhonda Weeks, Barnes Retina Institute
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectony Surgery and Controls
Progression of nuclear sclerotic cataract after pars plana vitrectomy has been recognized for many years The mechanism for the rapid progression of nuclear sclerotic cataract remains unclear.
The objective of this trial is to evaluate and compare the level and progression of cataract advancement in controls versus eyes that have undergone 20-gauge pars plana vitrectomy and 25-gauge pars plana vitrectomy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Approximately 105 patients will be recruited to obtain 35 control eyes that have not had pars plana vitrectomy and 35 eyes who will have undergone 20-gauge pars plana vitrectomy and 35 eyes will have undergone 25-gauge pars plana vitrectomy.
Scheimpflug crystalline lens photographs will be taken for evaluation of level and progression of cataract development.
Study Type
Observational
Enrollment (Actual)
49
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
St. Louis, Missouri, United States, 63110
- Barnes Retina Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients undergoing vitrectony surgery and controls
Description
Inclusion Criteria:
- phakic eyes of patients that are scheduled to undergo pars plana vitrectomy,
- controls will be phakic eyes of patients that have not undergone andy kind of intraocular surgery,
- age 18 and older
Exclusion Criteria:
- any eye that is pseudophakic,
- has had previous vitreoretinal surgery,
- has had previous intravitreal injection,
- previous intraocular inflammatory condition such as uveitis,
- previous irradiation,
- any patient with a history of ocular malignancy,
- history of infectious intraocular condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2006
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
November 30, 2006
First Submitted That Met QC Criteria
November 30, 2006
First Posted (Estimate)
December 4, 2006
Study Record Updates
Last Update Posted (Estimate)
July 27, 2016
Last Update Submitted That Met QC Criteria
July 25, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06-1016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nuclear Sclerotic Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Matthew RauenCompletedNuclear CataractUnited States
-
Matthew RauenRecruitingNuclear CataractUnited States
-
Chakshu Research, Inc.Unknown
-
Lenstatin LLCCompleted
-
Oogziekenhuis RotterdamCarl Zeiss Meditec AG; Stichting Wetenschappelijk Onderzoek Het Oogziekenhuis...RecruitingNuclear CataractNetherlands
-
Yune ZhaoUnknownHard Nuclear Cataract | Corneal Endothelial Cell | Progressive Cracking TechniqueChina
-
University of Texas Southwestern Medical CenterCompletedIncipient Cataract | Senile Nuclear SclerosisUnited States
-
Alterman, Modi, & Wolter Ophthalmic Physicians...CompletedCataract | Astigmatism | Cortical Cataract | Nuclear Sclerosis | Posterior Subcapsular CataractUnited States
-
Steve H. Linn, ODCompletedCortical Cataract | Posterior Subcapsular Cataract | Nuclear Sclerosis of the LensUnited States
Clinical Trials on Scheimpflug crystalline lens photographs
-
Moorfields Eye Hospital NHS Foundation TrustCompleted